ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,830Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 262

$434K Total Retail Price of All Prescriptions

Rank: 39 out of 262

446 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,459 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 441 400 1 4
OMEPRAZOLE 426 344 2 5
SIMVASTATIN 366 328 3 1
LEVOTHYROXINE SODIUM 321 315 4 2
CITALOPRAM HBR 305 254 5 20
LISINOPRIL 304 281 6 3
AMLODIPINE BESYLATE 251 239 7 6
METOPROLOL TARTRATE 227 214 8 8
POTASSIUM CHLORIDE 213 196 9 10
SERTRALINE HCL 204 195 10 14
WARFARIN SODIUM 191 191 11 12
POLYETHYLENE GLYCOL 3350 170 152 12 42
HYDROCODONE-ACETAMINOPHEN 155 80 S3 13 15
TRAMADOL HCL 144 102 14 18
GABAPENTIN 135 94 15 19
METOPROLOL SUCCINATE 128 128 16 11
HYDROCHLOROTHIAZIDE 124 116 17 7
TRAZODONE HCL 121 104 18 36
METFORMIN HCL 121 105 18 9
PAROXETINE HCL 109 80 20 56
DONEPEZIL HCL 109 109 20 23
ATENOLOL 98 86 22 16
MIRTAZAPINE 95 80 23 35
FENTANYL 95 95 S2 23 40
ALENDRONATE SODIUM 94 84 25 21
NAMENDA 93 93 26 37
ADVAIR DISKUS 86 74 27 34
MELOXICAM 85 63 28 54
QUETIAPINE FUMARATE 82 77 29 71
ZOLPIDEM TARTRATE 76 66 30 26
RISPERIDONE 72 33 31 50
LACTULOSE 71 30 32 131
ATORVASTATIN CALCIUM 70 70 33 13
PREDNISONE 67 48 34 29
ESCITALOPRAM OXALATE 63 54 35 83
FLUOXETINE HCL 63 46 35 46
DIGOXIN 61 61 37 28
LOSARTAN POTASSIUM 61 58 37 17
INSULIN SYRINGE 60 48 39 85
CIPROFLOXACIN HCL 59 54 40 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 43 41 93
LANTUS 51 51 42 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.